Explore how India's 20-year product patent regime transformed its pharma industry from generics to innovation, the economic ...

The Federal Circuit recently considered the scope of a permanent injunction that prohibited a drug manufacturer from ...

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

Vepdegestrant showed a benefit for patients with ER-positive, HER2-negative, ESR1-mutated breast cancer who had previously received endocrine-based therapy.

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Kura Oncology and Kyowa Kirin submitted data from the KOMET-001 trial, which the agency will review and decide whether to approve the drug by Nov. 30.

The Platform Technology Designation, which predates the current FDA leadership, is designed to streamline the drug ...

A pop-up overdose prevention tent is now running once a week in downtown St. John's. Overdose Awareness and Response St.

GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) will soon submit its new drug application (NDA) ...

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...